BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16

• Press Releases

  Invivyd Announces Receipt of Twelve Months’ Advanced Notice of Emergency Use Authorization (EUA) Termination for PEMGARDA® and Provides an Update on Next Steps with the U.S. FDA

  July 6, 2026

   · 

  11 min read
• Press Releases

  Pluristyx Inc. Secures Initial Close of Series A Priced Round with Multinational Fortune 500 Company; Round to Remain Open for Syndicate Partners Until September 2nd

  July 6, 2026

   · 

  2 min read
• Press Releases

  VERAXA Biotech Provides Business Update and Further Details on Partnering Strategy and Development Timelines

  July 6, 2026

   · 

  4 min read
• Press Releases

  Opus Genetics Announces FDA Alignment on Phase 3 Registrational Trial Design for OPGx-LCA5 in LCA5-Associated Inherited Retinal Disease

  July 6, 2026

   · 

  6 min read
• Press Releases

  Seer Files Investor Presentation Highlighting Strong Momentum, Commercial Opportunity and Significant Long-Term Value Creation Potential

  July 6, 2026

   · 

  6 min read
• Press Releases

  Grey Matters Takes Delivery of the First Brain Dedicated PET Scanning System for its Flagship NovaScan Neuroimaging Clinic in Florida

  July 6, 2026

   · 

  5 min read
• Press Releases

  Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences

  July 6, 2026

   · 

  3 min read
• Press Releases

  Can-Fite Achieves Key Pivotal Phase 3 Psoriasis Milestone with Completion of Patient Enrolment for the Interim Analysis: Data Expected Q4 2026/Q1 2027

  July 6, 2026

   · 

  6 min read
• Press Releases

  Ozempic® Savings Card Program Expanded for Patients with Private Coverage

  July 6, 2026

   · 

  2 min read
• Press Releases

  LSL PHARMA GROUP PROVIDES UPDATE ON STERI-MED PHARMA MANUFACTURING OPERATIONS AND GRANTS COMPENSATION STOCK OPTIONS

  July 6, 2026

   · 

  4 min read